zoledronic acid has been researched along with Osteomyelitis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Abdelghani, K; Chekili, S; Fazaa, A; Laatar, A; Makhlouf, Y; Miladi, S; Sallemi, M | 1 |
| Díaz-Cordovés Rego, G; Galindo Zavala, R; González Vázquez, E; Martín Pedraz, L; Núñez Cuadros, E | 1 |
| Fujita, R; Hamano, H; Hiratsuka, S; Iwasaki, N; Kobayashi, H; Sato, D; Shimizu, T; Takahata, M | 1 |
| Burnham, JM; Chauvin, NA; Jaramillo, D; Zhao, Y | 1 |
| Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A | 1 |
| de Jong, E; Hamdy, NA; Kuijpers, SC; van Merkesteyn, JP | 1 |
| Pazianas, M | 1 |
| Nathan, C; Phillips, JM; Thibodeaux, JD | 1 |
| Bartl, R | 1 |
| Grätz, KW; Jacobsen, C; Metzler, P; Obwegeser, J; Rössle, M; Zemann, W | 1 |
| Tanvetyanon, T | 1 |
| Fietkau, R; Gundlach, KK; Lenz, JH; Mueller, PC; Schmidt, W; Steiner-Krammer, B | 1 |
| Englund, K; Hatch, C; Hussein, MA; Isada, C; Karam, MA; Licata, A; Reed, J; Richmond, M; Smith, J; Thakkar, SG; Tomford, JW | 1 |
| Weeda, LW | 1 |
| Bellomi, M; Bruschini, R; Cossu Rocca, M; Goldhirsch, A; Nole, F; Preda, L; Sanna, G; Verri, E | 1 |
| Casas, N; Delmas, PD; Eriksen, EF; Grbic, JT; Hua, Y; Landesberg, R; Leung, PC; Lin, SQ; Mesenbrink, P; Recknor, CP; Reid, IR | 1 |
2 review(s) available for zoledronic acid and Osteomyelitis
| Article | Year |
|---|---|
Osteonecrosis of the jaw and the role of macrophages.
Topics: Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Density Conservation Agents; Denosumab; Diphosphonates; Etidronic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Imidazoles; Indoles; Jaw Diseases; Macrophages; Magnetic Resonance Imaging; Mevalonic Acid; Monocytes; Mouth Mucosa; Osteoclasts; Osteomyelitis; Osteonecrosis; Positron-Emission Tomography; Pyrroles; Radiography, Panoramic; RANK Ligand; Risedronic Acid; Risk Factors; Signal Transduction; Sunitinib; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid | 2011 |
Skull base osteomyelitis and bisphosphonate use in multiple myeloma: report of two cases and literature review.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteomyelitis; Retrospective Studies; Skull Base; Tomography, X-Ray Computed; Zoledronic Acid | 2010 |
1 trial(s) available for zoledronic acid and Osteomyelitis
| Article | Year |
|---|---|
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Epidemiologic Methods; Female; Hip Fractures; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteitis; Osteomyelitis; Osteonecrosis; Osteoporosis, Postmenopausal; Periapical Abscess; Zoledronic Acid | 2008 |
13 other study(ies) available for zoledronic acid and Osteomyelitis
| Article | Year |
|---|---|
Zoledronate-Associated Seizure in Chronic Recurrent Multifocal Osteomyelitis.
Topics: Child; Diphosphonates; Female; Humans; Osteomyelitis; Seizures; Zoledronic Acid | 2022 |
Is zoledronate a safe and effective treatment option in chronic nonbacterial osteomyelitis?
Topics: Humans; Osteomyelitis; Treatment Outcome; Zoledronic Acid | 2023 |
Differential effects of anti-RANKL monoclonal antibody and zoledronic acid on necrotic bone in a murine model of Staphylococcus aureus-induced osteomyelitis.
Topics: Animals; Antibodies, Monoclonal; Bone Density Conservation Agents; Disease Models, Animal; Ligands; Mice; Osteoclasts; Osteolysis; Osteomyelitis; Osteonecrosis; RANK Ligand; Staphylococcal Infections; Staphylococcus aureus; X-Ray Microtomography; Zoledronic Acid | 2022 |
Aggressive Therapy Reduces Disease Activity without Skeletal Damage Progression in Chronic Nonbacterial Osteomyelitis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Bone Density Conservation Agents; Child; Diphosphonates; Disease Progression; Drug Therapy, Combination; Female; Humans; Imidazoles; Infliximab; Magnetic Resonance Imaging; Male; Methotrexate; Osteomyelitis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Zoledronic Acid | 2015 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid | 2010 |
Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pamidronate; Radionuclide Imaging; Recurrence; Sclerosis; Treatment Outcome; Young Adult; Zoledronic Acid | 2011 |
[Inflammation of the jaws during treatment with bisphosphonates].
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Drug Approval; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Opportunistic Infections; Osteomyelitis; Osteonecrosis; Osteoporosis; Pamidronate; Practice Guidelines as Topic; Risk Factors; Zoledronic Acid | 2011 |
Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Topics: Actinomycosis; Administration, Intravenous; Administration, Oral; Alendronate; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Debridement; Dental Implants; Diphosphonates; Female; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Male; Mandible; Mandibular Neoplasms; Maxilla; Neoplasms; Osteomyelitis; Osteoporosis; Pamidronate; Risk Factors; Time Factors; Zoledronic Acid | 2013 |
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Jaw; Male; Necrosis; Osteomyelitis; Osteopetrosis; Pain; Pain Measurement; Pamidronate; Prostatic Neoplasms; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Zoledronic Acid | 2005 |
Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Mandibular Diseases; Maxillary Diseases; Multiple Myeloma; Osteomyelitis; Osteonecrosis; Zoledronic Acid | 2005 |
Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.
Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteomyelitis; Osteonecrosis; Pamidronate; Paraproteinemias; Zoledronic Acid | 2006 |
Drug induced osteonecrosis of the jaws.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Osteoclasts; Osteomyelitis; Osteonecrosis; Pamidronate; Splints; Zoledronic Acid | 2006 |
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.
Topics: Adenocarcinoma; Bone Neoplasms; Bone Plates; Bone Screws; Breast Neoplasms; Cutaneous Fistula; Diphosphonates; Female; Humans; Imidazoles; Male; Mandible; Mandibular Diseases; Middle Aged; Necrosis; Oral Fistula; Osteolysis; Osteomyelitis; Pamidronate; Prostatic Neoplasms; Recurrence; Tomography, X-Ray Computed; Zoledronic Acid | 2008 |